TruAlt Bioenergy Limited Q4 FY26 earnings call summary

Earnings call of 22 May 2026, summarised by AI from the filing.

OMC allocation methodology and non-implementation of 15 crore litres court order delayed revenue.

Key takeaways

1. Risk OMC allocation methodology and non-implementation of 15 crore litres court order delayed revenue.

Original filing on BSE

TruAlt Bioenergy Limited Q1 FY27 results

As filed: Revenue ₹627 cr (+106% year on year), EBITDA ₹133 cr (+216% year on year), PAT ₹59.3 cr (+300% year on year), EBITDA margin 21.2% (+736 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

• Q4 FY26: Revenue ₹603 cr, EBITDA ₹131 cr, PAT ₹56.7 cr, EBITDA margin 21.7%. Not scored. No result for the same quarter last year. Share price after the results: −0.7% in 28 days (Nifty 500: +2.2%).
• Q3 FY26: Revenue ₹703 cr, EBITDA ₹129 cr, PAT ₹66.0 cr, EBITDA margin 18.4%. Not scored. No result for the same quarter last year. Share price after the results: −6.8% in 30 days (Nifty 500: −3.2%).
• Q2 FY26: Revenue ₹104 cr, EBITDA −₹12.0 cr, PAT −₹43.0 cr, EBITDA margin -11.5%. Not scored. No result for the same quarter last year. Share price after the results: −2.1% in 30 days (Nifty 500: +1.0%).
• Q1 FY26: Revenue ₹294 cr, EBITDA ₹34.0 cr, PAT ₹0.0 cr, EBITDA margin 11.6%. Not scored. No result for the same quarter last year.

Past price moves after results do not indicate future moves. Not a recommendation.

TruAlt Bioenergy Limited earnings call, investor presentation and press release summaries

• Q1 FY27: Earnings call (29 Jul 2026), Results deck (28 Jul 2026)
• Q4 FY26: Earnings call (22 May 2026), Results deck (22 May 2026)
• Q3 FY26: Earnings call (9 Feb 2026), Results deck (3 Feb 2026), Results press release (4 Feb 2026)
• Q2 FY26: Earnings call (13 Nov 2025), Results deck (11 Nov 2025)
• Q1 FY26: Results deck (19 Oct 2025)